| Year |
Citation |
Score |
| 2020 |
Moryl N, Filkins A, Griffo Y, Malhotra V, Jain RH, Frierson E, Inturrisi C. Successful use of buprenorphine-naloxone medication-assisted program to treat concurrent pain and opioid addiction after cancer therapy. Journal of Opioid Management. 16: 111-118. PMID 32329886 DOI: 10.5055/Jom.2020.0557 |
0.417 |
|
| 2019 |
Moryl N, Bokhari A, Griffo Y, Hadler R, Koranteng L, Filkins A, Zheng T, Horn SD, Inturrisi CE. Does transdermal fentanyl work in patients with low BMI? Patient-reported outcomes of pain and percent pain relief in cancer patients on transdermal fentanyl. Cancer Medicine. PMID 31568684 DOI: 10.1002/Cam4.2479 |
0.328 |
|
| 2019 |
Hanania T, Manfredi P, Inturrisi C, Vitolo OV. The N-methyl-D-aspartate receptor antagonist d-methadone acutely improves depressive-like behavior in the forced swim test performance of rats. Experimental and Clinical Psychopharmacology. PMID 31368772 DOI: 10.1037/Pha0000310 |
0.328 |
|
| 2019 |
Bernstein G, Davis K, Mills C, Wang L, McDonnell M, Oldenhof J, Inturrisi C, Manfredi PL, Vitolo OV. Characterization of the Safety and Pharmacokinetic Profile of D-Methadone, a Novel N-Methyl-D-Aspartate Receptor Antagonist in Healthy, Opioid-Naive Subjects: Results of Two Phase 1 Studies. Journal of Clinical Psychopharmacology. PMID 30939592 DOI: 10.1097/Jcp.0000000000001035 |
0.385 |
|
| 2017 |
Moryl N, Dave V, Glare P, Bokhari A, Malhotra VT, Gulati A, Hung J, Puttanniah V, Griffo Y, Tickoo R, Wiesenthal A, Horn SD, Inturrisi CE. Patient-Reported Outcomes and Opioid Use by Outpatient Cancer Patients. The Journal of Pain : Official Journal of the American Pain Society. PMID 29154919 DOI: 10.1016/J.Jpain.2017.11.001 |
0.401 |
|
| 2017 |
Malhotra VT, Glare P, Tan KS, Wills J, Gulati A, Puttanniah V, Hung J, Cubert K, Inturrisi C. The Tri-Institutional Pain Registry-Analysis of Outpatient Pain Management at a Specialized Cancer Center. Pain Medicine (Malden, Mass.). PMID 29016931 DOI: 10.1093/Pm/Pnx136 |
0.315 |
|
| 2017 |
Witkin LR, Zylberger D, Mehta N, Hindenlang M, Johnson C, Kean J, Horn SD, Inturrisi CE. Patient-Reported Outcomes and Opioid Use In Outpatients with Chronic Pain. The Journal of Pain : Official Journal of the American Pain Society. PMID 28088507 DOI: 10.1016/J.Jpain.2016.12.018 |
0.39 |
|
| 2016 |
Witkin L, Zylberger D, Mehta N, Hindenlang M, Johnson C, Horn S, Inturrisi C. (452) The influence of age and gender on opioid dosage in chronic noncancer pain clinic patients. The Journal of Pain : Official Journal of the American Pain Society. 17: S87. PMID 28162700 DOI: 10.1016/J.Jpain.2016.01.429 |
0.392 |
|
| 2016 |
Moryl N, Dave V, Glare P, Malhotra V, Gulati A, Hung J, Puttanniah V, Griffo Y, Tickoo R, Wiesenthal A, Johnson C, Horn S, Inturrisi C. (386) The influence of age and gender on opioid dosage in cancer pain clinic patients. The Journal of Pain : Official Journal of the American Pain Society. 17: S71. PMID 28162629 DOI: 10.1016/J.Jpain.2016.01.363 |
0.372 |
|
| 2016 |
Cea M, Reid MC, Inturrisi C, Witkin LR, Prigerson HG, Bao Y. Pain assessment, management, and control among patients 65 years or older receiving hospice care in the U.S. Journal of Pain and Symptom Management. PMID 27693900 DOI: 10.1016/J.Jpainsymman.2016.05.020 |
0.302 |
|
| 2015 |
Dave V, Roberts R, Griffo Y, Moryl N, Tickoo R, Cubert K, Gulati A, Hung J, Puttanniah V, Horn S, Brown P, Malhotra V, Glare PA, Inturrisi C. Association of severe pain with poor response to opioids, psychological distress, and aberrant drug taking behaviors in a large cohort of cancer patients. Journal of Clinical Oncology. 33: 9600-9600. DOI: 10.1200/Jco.2015.33.15_Suppl.9600 |
0.399 |
|
| 2014 |
Chou R, Cruciani RA, Fiellin DA, Compton P, Farrar JT, Haigney MC, Inturrisi C, Knight JR, Otis-Green S, Marcus SM, Mehta D, Meyer MC, Portenoy R, Savage S, Strain E, et al. Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society. The Journal of Pain : Official Journal of the American Pain Society. 15: 321-37. PMID 24685458 DOI: 10.1016/J.Jpain.2014.01.494 |
0.371 |
|
| 2013 |
Xu J, Xu M, Brown T, Rossi GC, Hurd YL, Inturrisi CE, Pasternak GW, Pan YX. Stabilization of the μ-opioid receptor by truncated single transmembrane splice variants through a chaperone-like action. The Journal of Biological Chemistry. 288: 21211-27. PMID 23760268 DOI: 10.1074/Jbc.M113.458687 |
0.383 |
|
| 2013 |
Bruehl S, Apkarian AV, Ballantyne JC, Berger A, Borsook D, Chen WG, Farrar JT, Haythornthwaite JA, Horn SD, Iadarola MJ, Inturrisi CE, Lao L, Mackey S, Mao J, Sawczuk A, et al. Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges. The Journal of Pain : Official Journal of the American Pain Society. 14: 103-13. PMID 23374939 DOI: 10.1016/J.Jpain.2012.10.016 |
0.409 |
|
| 2011 |
Schierberl K, Hao J, Tropea TF, Ra S, Giordano TP, Xu Q, Garraway SM, Hofmann F, Moosmang S, Striessnig J, Inturrisi CE, Rajadhyaksha AM. Cav1.2 L-type Ca²⺠channels mediate cocaine-induced GluA1 trafficking in the nucleus accumbens, a long-term adaptation dependent on ventral tegmental area Ca(v)1.3 channels. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 13562-75. PMID 21940447 DOI: 10.1523/Jneurosci.2315-11.2011 |
0.536 |
|
| 2011 |
Reid MC, Bennett DA, Chen WG, Eldadah BA, Farrar JT, Ferrell B, Gallagher RM, Hanlon JT, Herr K, Horn SD, Inturrisi CE, Lemtouni S, Lin YW, Michaud K, Morrison RS, et al. Improving the pharmacologic management of pain in older adults: identifying the research gaps and methods to address them. Pain Medicine (Malden, Mass.). 12: 1336-57. PMID 21834914 DOI: 10.1111/J.1526-4637.2011.01211.X |
0.326 |
|
| 2011 |
Hunter DA, Barr GA, Shivers KY, Amador N, Jenab S, Inturrisi C, Quinones-Jenab V. Interactions of estradiol and NSAIDS on carrageenan-induced hyperalgesia. Brain Research. 1382: 181-8. PMID 21281615 DOI: 10.1016/J.Brainres.2011.01.075 |
0.333 |
|
| 2011 |
Hunter DA, Barr GA, Amador N, Shivers KY, Kemen L, Kreiter CM, Jenab S, Inturrisi CE, Quinones-Jenab V. Estradiol-induced antinociceptive responses on formalin-induced nociception are independent of COX and HPA activation. Synapse (New York, N.Y.). 65: 643-51. PMID 21132813 DOI: 10.1002/Syn.20890 |
0.342 |
|
| 2010 |
Chapman CR, Lipschitz DL, Angst MS, Chou R, Denisco RC, Donaldson GW, Fine PG, Foley KM, Gallagher RM, Gilson AM, Haddox JD, Horn SD, Inturrisi CE, Jick SS, Lipman AG, et al. Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base. The Journal of Pain : Official Journal of the American Pain Society. 11: 807-29. PMID 20430701 DOI: 10.1016/J.Jpain.2010.02.019 |
0.399 |
|
| 2010 |
Gregus AM, Inra CN, Giordano TP, Costa AC, Rajadhyaksha AM, Inturrisi CE. Spinal mediators that may contribute selectively to antinociceptive tolerance but not other effects of morphine as revealed by deletion of GluR5. Neuroscience. 169: 475-87. PMID 20359526 DOI: 10.1016/J.Neuroscience.2010.03.051 |
0.801 |
|
| 2010 |
Weyerbacher AR, Xu Q, Tamasdan C, Shin SJ, Inturrisi CE. N-Methyl-D-aspartate receptor (NMDAR) independent maintenance of inflammatory pain. Pain. 148: 237-46. PMID 20005044 DOI: 10.1016/J.Pain.2009.11.003 |
0.785 |
|
| 2010 |
Gregus AM, Tropea TF, Wang Y, Hauck SC, Costa AC, Rajadhyaksha AM, Inturrisi CE. Deletion of the GluR5 subunit of kainate receptors affects cocaine sensitivity and preference. Neuroscience Letters. 468: 186-9. PMID 19878705 DOI: 10.1016/J.Neulet.2009.10.071 |
0.767 |
|
| 2009 |
Klein G, Rossi GC, Waxman AR, Arout C, Juni A, Inturrisi CE, Kest B. The contribution of MOR-1 exons 1-4 to morphine and heroin analgesia and dependence. Neuroscience Letters. 457: 115-9. PMID 19429175 DOI: 10.1016/J.Neulet.2009.04.012 |
0.442 |
|
| 2009 |
Garraway SM, Xu Q, Inturrisi CE. siRNA-mediated knockdown of the NR1 subunit gene of the NMDA receptor attenuates formalin-induced pain behaviors in adult rats. The Journal of Pain : Official Journal of the American Pain Society. 10: 380-90. PMID 19185544 DOI: 10.1016/J.Jpain.2008.09.013 |
0.628 |
|
| 2009 |
Bogulavsky JJ, Gregus AM, Kim PT, Costa AC, Rajadhyaksha AM, Inturrisi CE. Deletion of the glutamate receptor 5 subunit of kainate receptors affects the development of morphine tolerance. The Journal of Pharmacology and Experimental Therapeutics. 328: 579-87. PMID 18957577 DOI: 10.1124/Jpet.108.144121 |
0.764 |
|
| 2009 |
Inturrisi CE. Pharmacology of analgesia: Basic principles Cancer Pain: Assessment and Management, Second Edition. 167-179. DOI: 10.1017/CBO9780511642357.010 |
0.318 |
|
| 2009 |
Weyerbacher A, Tamasdan C, Inturrisi C. The N-Methyl-D-Aspartate Receptor (NMDAR) and neuronal-glial-cytokine interactions that initiate and maintain inflammatory pain The Journal of Pain. 10: S28. DOI: 10.1016/J.Jpain.2009.01.120 |
0.779 |
|
| 2008 |
Xu Q, Garraway SM, Weyerbacher AR, Shin SJ, Inturrisi CE. Activation of the neuronal extracellular signal-regulated kinase 2 in the spinal cord dorsal horn is required for complete Freund's adjuvant-induced pain hypersensitivity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 14087-96. PMID 19109491 DOI: 10.1523/Jneurosci.2406-08.2008 |
0.774 |
|
| 2008 |
Cheng HT, Suzuki M, Hegarty DM, Xu Q, Weyerbacher AR, South SM, Ohata M, Inturrisi CE. Inflammatory pain-induced signaling events following a conditional deletion of the N-methyl-D-aspartate receptor in spinal cord dorsal horn. Neuroscience. 155: 948-58. PMID 18621103 DOI: 10.1016/J.Neuroscience.2008.06.024 |
0.785 |
|
| 2008 |
Glass MJ, Hegarty DM, Oselkin M, Quimson L, South SM, Xu Q, Pickel VM, Inturrisi CE. Conditional deletion of the NMDA-NR1 receptor subunit gene in the central nucleus of the amygdala inhibits naloxone-induced conditioned place aversion in morphine-dependent mice. Experimental Neurology. 213: 57-70. PMID 18614169 DOI: 10.1016/J.Expneurol.2008.04.045 |
0.787 |
|
| 2008 |
Klein G, Juni A, Waxman AR, Arout CA, Inturrisi CE, Kest B. A survey of acute and chronic heroin dependence in ten inbred mouse strains: evidence of genetic correlation with morphine dependence. Pharmacology, Biochemistry, and Behavior. 90: 447-52. PMID 18472145 DOI: 10.1016/J.Pbb.2008.03.030 |
0.351 |
|
| 2008 |
Klein G, Juni A, Arout CA, Waxman AR, Inturrisi CE, Kest B. Acute and chronic heroin dependence in mice: contribution of opioid and excitatory amino acid receptors. European Journal of Pharmacology. 586: 179-88. PMID 18343363 DOI: 10.1016/J.Ejphar.2008.02.035 |
0.453 |
|
| 2008 |
Gordon D, Inturrisi CE, Greensmith JE, Brennan TJ, Goble L, Kerns RD. Perioperative pain management in the opioid-tolerant individual. The Journal of Pain : Official Journal of the American Pain Society. 9: 383-7. PMID 18337186 DOI: 10.1016/J.Jpain.2008.01.331 |
0.398 |
|
| 2008 |
Maingi S, Moryl N, Inturrisi C. 242) Marked and sustained reduction of opioid requirements after administration of intravenous naloxone for respiratory depression The Journal of Pain. 9: 36. DOI: 10.1016/J.Jpain.2008.01.163 |
0.344 |
|
| 2008 |
Tamasdan C, Moryl N, Tarcatu D, Weyerbacher A, Jahdi M, Faskowitz A, Obbens E, Inturrisi C. (194) Transfusion-induced opioid requirements: Results of a first clinical study and its consequences The Journal of Pain. 9: 24. DOI: 10.1016/J.Jpain.2008.01.115 |
0.778 |
|
| 2008 |
Martino D, Tamasdan C, Moryl N, Inturrisi C. 193) Concurrent use of ketamine and methadone in severe cancer pain The Journal of Pain. 9: 24. DOI: 10.1016/J.Jpain.2008.01.114 |
0.324 |
|
| 2008 |
Weyerbacher A, Tamasdan C, Xu Q, Cheng H, Inturrisi C. (137) Cellular localization of inflammatory pain signaling in spinal cord dorsal horn The Journal of Pain. 9: 10. DOI: 10.1016/J.Jpain.2008.01.056 |
0.768 |
|
| 2007 |
Garraway SM, Xu Q, Inturrisi CE. Design and evaluation of small interfering RNAs that target expression of the N-methyl-D-aspartate receptor NR1 subunit gene in the spinal cord dorsal horn. The Journal of Pharmacology and Experimental Therapeutics. 322: 982-8. PMID 17551091 DOI: 10.1124/Jpet.107.123125 |
0.634 |
|
| 2007 |
Mannino CA, South SM, Quinones-Jenab V, Inturrisi CE. Estradiol replacement in ovariectomized rats is antihyperalgesic in the formalin test. The Journal of Pain : Official Journal of the American Pain Society. 8: 334-42. PMID 17140856 DOI: 10.1016/J.Jpain.2006.10.002 |
0.757 |
|
| 2007 |
Garraway S, Xu Q, Inturrisi C. (650/Paper 312) The Journal of Pain. 8: S13. DOI: 10.1016/J.Jpain.2007.02.061 |
0.468 |
|
| 2006 |
Pasternak GW, Inturrisi CE. Feeling pain? Who's your daddy.... Nature Medicine. 12: 1243-4. PMID 17088889 DOI: 10.1038/Nm1106-1243 |
0.321 |
|
| 2006 |
Kuba T, Wu HB, Nazarian A, Festa ED, Barr GA, Jenab S, Inturrisi CE, Quinones-Jenab V. Estradiol and progesterone differentially regulate formalin-induced nociception in ovariectomized female rats. Hormones and Behavior. 49: 441-9. PMID 16257405 DOI: 10.1016/J.Yhbeh.2005.09.007 |
0.386 |
|
| 2006 |
Inturrisi CE. Characterization of Pain Receptors in the Spinal Cord Using a Viral Vector for Spatial-Temporal Gene Targeting Gene Therapy of the Central Nervous System: From Bench to Bedside. 223-229. DOI: 10.1016/B978-012397632-1/50018-6 |
0.331 |
|
| 2005 |
Mannino CA, South SM, Inturrisi CE, Quinones-Jenab V. Pharmacokinetics and effects of 17beta-estradiol and progesterone implants in ovariectomized rats. The Journal of Pain : Official Journal of the American Pain Society. 6: 809-16. PMID 16326369 DOI: 10.1016/J.Jpain.2005.07.007 |
0.75 |
|
| 2005 |
Inturrisi CE. Pharmacology of methadone and its isomers Minerva Anestesiologica. 71: 435-437. PMID 16012416 |
0.352 |
|
| 2005 |
Inturrisi CE. The role of N-methyl-D-aspartate (NMDA) receptors in pain and morphine tolerance Minerva Anestesiologica. 71: 401-403. PMID 16012411 |
0.368 |
|
| 2005 |
Shimoyama N, Shimoyama M, Davis AM, Monaghan DT, Inturrisi CE. An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance. The Journal of Pharmacology and Experimental Therapeutics. 312: 834-40. PMID 15388787 DOI: 10.1124/Jpet.104.074856 |
0.447 |
|
| 2003 |
Jenab S, Festa ED, Russo SJ, Wu HB, Inturrisi CE, Quinones-Jenab V. MK-801 attenuates cocaine induction of c-fos and preprodynorphin mRNA levels in Fischer rats. Brain Research. Molecular Brain Research. 117: 237-9. PMID 14559159 DOI: 10.1016/S0169-328X(03)00319-X |
0.321 |
|
| 2003 |
Manfredi PL, Foley KM, Payne R, Houde R, Inturrisi CE. Parenteral methadone: an essential medication for the treatment of pain. Journal of Pain and Symptom Management. 26: 687-8. PMID 12906950 DOI: 10.1016/S0885-3924(03)00259-8 |
0.306 |
|
| 2003 |
Walker JR, Chen SA, Moffitt H, Inturrisi CE, Koob GF. Chronic opioid exposure produces increased heroin self-administration in rats. Pharmacology, Biochemistry, and Behavior. 75: 349-54. PMID 12873626 DOI: 10.1016/S0091-3057(03)00094-7 |
0.362 |
|
| 2003 |
South SM, Kohno T, Kaspar BK, Hegarty D, Vissel B, Drake CT, Ohata M, Jenab S, Sailer AW, Malkmus S, Masuyama T, Horner P, Bogulavsky J, Gage FH, Yaksh TL, ... ... Inturrisi CE, et al. A conditional deletion of the NR1 subunit of the NMDA receptor in adult spinal cord dorsal horn reduces NMDA currents and injury-induced pain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 5031-40. PMID 12832526 DOI: 10.1523/Jneurosci.23-12-05031.2003 |
0.763 |
|
| 2003 |
Zhu H, Brodsky M, Gorman AL, Inturrisi CE. Region-specific changes in NMDA receptor mRNA induced by chronic morphine treatment are prevented by the co-administration of the competitive NMDA receptor antagonist LY274614. Brain Research. Molecular Brain Research. 114: 154-62. PMID 12829326 DOI: 10.1016/S0169-328X(03)00170-0 |
0.478 |
|
| 2003 |
Zhu H, Jenab S, Jones KL, Inturrisi CE. The clinically available NMDA receptor antagonist dextromethorphan attenuates acute morphine withdrawal in the neonatal rat. Brain Research. Developmental Brain Research. 142: 209-13. PMID 12711372 DOI: 10.1016/S0165-3806(03)00059-2 |
0.428 |
|
| 2002 |
Inturrisi CE. Clinical pharmacology of opioids for pain. The Clinical Journal of Pain. 18: S3-13. PMID 12479250 DOI: 10.1097/00002508-200207001-00002 |
0.476 |
|
| 2002 |
Jenab S, Inturrisi CE. Retinoic acid regulation of mu opioid receptor and c-fos mRNAs and AP-1 DNA binding in SH-SY5Y neuroblastoma cells. Brain Research. Molecular Brain Research. 99: 34-9. PMID 11869806 DOI: 10.1016/S0169-328X(01)00343-6 |
0.308 |
|
| 2002 |
Jones KL, Zhu H, Jenab S, Du T, Inturrisi CE, Barr GA. Attenuation of acute morphine withdrawal in the neonatal rat by the competitive NMDA receptor antagonist LY235959. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 301-10. PMID 11850145 DOI: 10.1016/S0893-133X(01)00347-5 |
0.442 |
|
| 2001 |
Davis AM, Inturrisi CE. Attenuation of hyperalgesia by LY235959, a competitive N-methyl-D-aspartate receptor antagonist Brain Research. 894: 150-153. PMID 11245826 DOI: 10.1016/S0006-8993(00)03325-4 |
0.375 |
|
| 1999 |
Shimoyama M, Shimoyama N, Gorman AL, Elliott KJ, Inturrisi CE. Oral ketamine is antinociceptive in the rat formalin test: role of the metabolite, norketamine. Pain. 81: 85-93. PMID 10353496 DOI: 10.1016/S0304-3959(98)00269-3 |
0.368 |
|
| 1999 |
Davis AM, Inturrisi CE. d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia Journal of Pharmacology and Experimental Therapeutics. 289: 1048-1053. PMID 10215686 |
0.31 |
|
| 1999 |
Collins JJ, Dunkel IJ, Gupta SK, Inturrisi CE, Lapin J, Palmer LN, Weinstein SM, Portenoy RK. Transdermal fentanyl in children with cancer pain: feasibility, tolerability, and pharmacokinetic correlates. The Journal of Pediatrics. 134: 319-23. PMID 10064669 DOI: 10.1016/S0022-3476(99)70457-9 |
0.31 |
|
| 1999 |
Kest B, Jenab S, Brodsky M, Sadowski B, Belknap JK, Mogil JS, Inturrisi CE. Mu and delta opioid receptor analgesia, binding density, and mRNA levels in mice selectively bred for high and low analgesia. Brain Research. 816: 381-9. PMID 9878841 DOI: 10.1016/S0006-8993(98)01141-X |
0.429 |
|
| 1999 |
Portenoy RK, Caraceni A, Cherny NI, Goldblum R, Ingham J, Inturrisi CE, Johnson JH, Lapin J, Tiseo PJ, Kreek MJ. Dynorphin A(1-13) analgesia in opioid-treated patients with chronic pain. A controlled pilot study Clinical Drug Investigation. 17: 33-42. DOI: 10.2165/00044011-199917010-00004 |
0.419 |
|
| 1999 |
Inturrisi CE. Old dogs, new tricks Pain Forum. 8: 210-212. DOI: 10.1016/S1082-3174(99)70011-5 |
0.466 |
|
| 1998 |
Kest B, McLemore GL, Sadowski B, Mogil JS, Belknap JK, Inturrisi CE. Acute morphine dependence in mice selectively-bred for high and low analgesia. Neuroscience Letters. 256: 120-2. PMID 9853718 DOI: 10.1016/S0304-3940(98)00772-1 |
0.408 |
|
| 1998 |
Kest B, Beczkowska I, Franklin SO, Lee CE, Mogil JS, Inturrisi CE. Differences in delta opioid receptor antinociception, binding, and mRNA levels between BALB/c and CXBK mice. Brain Research. 805: 131-7. PMID 9733948 DOI: 10.1016/S0006-8993(98)00696-9 |
0.432 |
|
| 1998 |
Kest B, Lee CE, Jenab S, Kao B, Inturrisi CE. Chronic naltrexone differentially affects supraspinal δ-opioid receptor-mediated antinociception European Journal of Pharmacology. 345: 47-53. PMID 9593593 DOI: 10.1016/S0014-2999(97)01584-7 |
0.438 |
|
| 1997 |
McLemore GL, Kest B, Inturrisi CE. The effects of LY293558, an AMPA receptor antagonist, on acute and chronic morphine dependence Brain Research. 778: 120-126. PMID 9462883 DOI: 10.1016/S0006-8993(97)00985-2 |
0.447 |
|
| 1997 |
Kest B, McLemore G, Kao B, Inturrisi CE. The competitive α-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to Delta or Kappa opioids Journal of Pharmacology and Experimental Therapeutics. 283: 1249-1255. PMID 9400000 |
0.353 |
|
| 1997 |
Lee CE, Kest B, Jenab S, Inturrisi CE. Effect of supraspinal antisense oligodeoxynucleotide treatment on δ-opioid receptor mRNA levels in mice Molecular Brain Research. 48: 17-22. PMID 9379841 DOI: 10.1016/S0169-328X(97)00054-5 |
0.415 |
|
| 1997 |
Shimoyama M, Shimoyama N, Inturrisi CE, Elliott KJ. Gabapentin enhances the antinociceptive effects of spinal morphine in the rat tail-flick test. Pain. 72: 375-82. PMID 9313278 DOI: 10.1016/S0304-3959(97)00065-1 |
0.439 |
|
| 1997 |
Quiñones-Jenab V, Jenab S, Ogawa S, Inturrisi C, Pfaff DW. Estrogen regulation of mu-opioid receptor mRNA in the forebrain of female rats. Brain Research. Molecular Brain Research. 47: 134-8. PMID 9221910 DOI: 10.1016/S0169-328X(97)00041-7 |
0.424 |
|
| 1997 |
Beczkowska IW, Gracy KN, Pickel VM, Inturrisi CE. Inducible expression of N-methyl-D-aspartate receptor, and delta and mu opioid receptor messenger RNAs and protein in the NT2-N human cell line. Neuroscience. 79: 855-62. PMID 9219948 DOI: 10.1016/S0306-4522(97)00034-1 |
0.396 |
|
| 1997 |
Shimoyama N, Shimoyama M, Davis AM, Inturrisi CE, Elliott KJ. Spinal gabapentin is antinociceptive in the rat formalin test. Neuroscience Letters. 222: 65-7. PMID 9121725 DOI: 10.1016/S0304-3940(97)13331-6 |
0.378 |
|
| 1997 |
Gorman AL, Elliott KJ, Inturrisi CE. The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neuroscience Letters. 223: 5-8. PMID 9058409 DOI: 10.1016/S0304-3940(97)13391-2 |
0.416 |
|
| 1997 |
Kest B, Lee CE, Mogil JS, Inturrisi CE. Blockade of morphine supersensitivity by an antisense oligodeoxynucleotide targeting the delta opioid receptor (DOR-1). Life Sciences. 60: PL155-9. PMID 9048971 DOI: 10.1016/S0024-3205(96)00704-7 |
0.443 |
|
| 1997 |
Beczkowska IW, Gracy KN, Pickel VM, Inturrisi CE. Detection of delta opioid receptor and N-methyl-D-aspartate receptor-like immunoreactivity in retinoic acid-differentiated neuroblastoma x glioma (NG108-15) cells. Journal of Neuroscience Research. 47: 83-9. PMID 8981241 DOI: 10.1002/(Sici)1097-4547(19970101)47:1<83::Aid-Jnr9>3.0.Co;2-B |
0.312 |
|
| 1997 |
Inturrisi CE. Preclinical evidence for a role of glutamatergic systems in opioid tolerance and dependence Seminars in the Neurosciences. 9: 110-119. DOI: 10.1006/Smns.1997.0111 |
0.409 |
|
| 1996 |
Bilsky EJ, Inturrisi CE, Sadée W, Hruby VJ, Porreca F. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective μ or δ opioid agonists in mice Pain. 68: 229-237. PMID 9121809 DOI: 10.1016/S0304-3959(96)03185-5 |
0.448 |
|
| 1996 |
Shimoyama N, Shimoyama M, Inturrisi CE, Elliott KJ. Ketamine attenuates and reverses morphine tolerance in rodents. Anesthesiology. 85: 1357-66. PMID 8968183 DOI: 10.1097/00000542-199612000-00017 |
0.457 |
|
| 1996 |
Payne R, Gradert TL, Inturrisi CE. Cerebrospinal fluid distribution of opioids after intraventricular and lumbar subarachnoid administration in sheep Life Sciences. 59: 1307-1321. PMID 8876660 DOI: 10.1016/0024-3205(96)00456-0 |
0.384 |
|
| 1996 |
Beczkowska IW, Buck J, Inturrisi CE. Retinoic acid-induced increase in delta-opioid receptor and N-methyl-D-aspartate receptor mRNA levels in neuroblastoma X glioma (NG108-15) cells Brain Research Bulletin. 39: 193-199. PMID 8866697 DOI: 10.1016/0361-9230(95)02104-3 |
0.324 |
|
| 1996 |
Kest B, Lee CE, McLemore GL, Inturrisi CE. An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice Brain Research Bulletin. 39: 185-188. PMID 8866695 DOI: 10.1016/0361-9230(95)02092-6 |
0.457 |
|
| 1995 |
Chan K, Brodsky M, Davis T, Franklin S, Inturrisi CE, Yoburn BC. The effect of the irreversible μ-opioid receptor antagonist clocinnamox on morphine potency, receptor binding and receptor mRNA European Journal of Pharmacology. 287: 135-143. PMID 8749027 DOI: 10.1016/0014-2999(95)00488-2 |
0.443 |
|
| 1995 |
Elliott K, Kest B, Man A, Kao B, Inturrisi CE. N-methyl-d-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development Neuropsychopharmacology. 13: 347-356. PMID 8747759 DOI: 10.1016/0893-133X(95)00083-P |
0.466 |
|
| 1995 |
Jenab S, Kest B, Inturrisi CE. Assessment of delta opioid antinociception and receptor mRNA levels in mouse after chronic naltrexone treatment Brain Research. 691: 69-75. PMID 8590066 DOI: 10.1016/0006-8993(95)00615-W |
0.399 |
|
| 1995 |
Bruera E, Watanabe S, Fainsinger RL, Spachynski K, Suarez-Almazor M, Inturrisi C. Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain Pain. 62: 141-146. PMID 8545138 DOI: 10.1016/0304-3959(94)00257-F |
0.316 |
|
| 1995 |
Elliott KJ, Brodsky M, Hynansky A, Foley KM, Inturrisi CE. Dextromethorphan shows efficacy in experimental pain (nociception) and opioid tolerance Neurology. 45: S66-S68. PMID 8545027 DOI: 10.1212/Wnl.45.12_Suppl_8.S66 |
0.407 |
|
| 1995 |
Jenab S, Kest B, Franklin SO, Inturrisi CE. Quantitative distribution of the delta opioid receptor mrna in the mouse and rat CNS Life Sciences. 56: 2343-2355. PMID 7791521 DOI: 10.1016/0024-3205(95)00228-X |
0.309 |
|
| 1995 |
Jenab S, Inturrisi CE. Proenkephalin gene expression: Interaction of glucocorticoid and cAMP regulatory elements Biochemical and Biophysical Research Communications. 210: 589-599. PMID 7755638 DOI: 10.1006/Bbrc.1995.1700 |
0.312 |
|
| 1995 |
Cheng PY, Svingos AL, Wang H, Clarke CL, Jenab S, Beczkowska IW, Inturrisi CE, Pickel VM. Ultrastructural immunolabeling shows prominent presynaptic vesicular localization of delta-opioid receptor within both enkephalin- and nonenkephalin-containing axon terminals in the superficial layers of the rat cervical spinal cord. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 5976-88. PMID 7666182 DOI: 10.1523/Jneurosci.15-09-05976.1995 |
0.394 |
|
| 1995 |
Tiseo PJ, Thaler HT, Lapin J, Inturrisi CE, Portenoy RK, Foley KM. Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients Pain. 61: 47-54. PMID 7644248 DOI: 10.1016/0304-3959(94)00148-8 |
0.334 |
|
| 1995 |
Rasmussen K, Brodsky M, Inturrisi CE. NMDA antagonists and clonidine block c-fos expression during morphine withdrawal Synapse. 20: 68-74. PMID 7624831 DOI: 10.1002/Syn.890200110 |
0.431 |
|
| 1995 |
Brodsky M, Elliott K, Hynansky A, Jenab S, Inturrisi CE. Quantitation of μ-opioid receptor (MOR-1) mRNA in selected regions of the rat CNS Neuroreport. 6: 725-729. PMID 7605935 DOI: 10.1097/00001756-199503270-00005 |
0.363 |
|
| 1995 |
Standifer KM, Jenab S, Su W, Chien CC, Pan YX, Inturrisi CE, Pasternak GW. Antisense oligodeoxynucleotides to the cloned δ receptor DOR-1: Uptake, stability, and regulation of gene expression Journal of Neurochemistry. 65: 1981-1987. PMID 7595481 DOI: 10.1046/J.1471-4159.1995.65051981.X |
0.418 |
|
| 1995 |
Brodsky M, Elliott K, Hynansky A, Inturrisi CE. CNS levels of mu opioid receptor (MOR-1) mRNA during chronic treatment with morphine or naltrexone Brain Research Bulletin. 38: 135-141. PMID 7583338 DOI: 10.1016/0361-9230(95)00079-T |
0.43 |
|
| 1995 |
Elliott KJ, Brodsky M, Hynansky AD, Foley KM, Inturrisi CE. Dextromethorphan suppresses both formalin-induced nociceptive behavior and the formalin-induced increase in spinal cord c-fos mRNA Pain. 61: 401-409. PMID 7478683 DOI: 10.1016/0304-3959(94)00214-Y |
0.34 |
|
| 1995 |
Kest B, Jenab S, Inturrisi CE. Levels of Delta-Opioid Receptor mRNA in Morphine-Tolerant Mice Analgesia. 1: 195-200. DOI: 10.3727/107156995819564257 |
0.323 |
|
| 1995 |
Kest B, Brodsky M, Sadowski B, Mogil J, Inturrisi C. MU OPIOID RECEPTOR (MOR-1) mRNA LEVELS ARE ALTERED IN MICE WITH DIFFERENTIAL ANALGESIC SENSITIVITY TO THE MU AGONIST DAMGO Analgesia. 1: 498-501. DOI: 10.3727/107156995819563492 |
0.313 |
|
| 1995 |
Pasternak GW, Inturrisi CE. Section review central & peripheral nervous systems: Pharmacological modulation of opioid tolerance Expert Opinion On Investigational Drugs. 4: 271-281. DOI: 10.1517/13543784.4.4.271 |
0.414 |
|
| 1994 |
Tiseo PJ, Cheng J, Pasternak GW, Inturrisi CE. Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: Assessment of opioid receptor changes Journal of Pharmacology and Experimental Therapeutics. 268: 195-201. PMID 8301558 |
0.356 |
|
| 1994 |
Gold LH, Stinus L, Inturrisi CE, Koob GF. Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat. European Journal of Pharmacology. 253: 45-51. PMID 8013548 DOI: 10.1016/0014-2999(94)90755-2 |
0.348 |
|
| 1994 |
Kest B, Jenab S, Brodsky M, Elliott K, Inturrisi CE. Supraspinal delta opioid receptor mRNA levels are not altered in [D- Ala2]deltorphin II tolerant mice Journal of Neuroscience Research. 39: 674-679. PMID 7897702 DOI: 10.1002/Jnr.490390608 |
0.362 |
|
| 1994 |
Jenab S, Inturrisi CE. Ethanol and naloxone differentially upregulate delta opioid receptor gene expression in neuroblastoma hybrid (NG108-15) cells Molecular Brain Research. 27: 95-102. PMID 7877460 DOI: 10.1016/0169-328X(94)90189-9 |
0.328 |
|
| 1994 |
Elliott K, Hynansky A, Inturrisi CE. Dextromethorphan attenuates and reverses analgesic tolerance to morphine Pain. 59: 361-368. PMID 7708410 DOI: 10.1016/0304-3959(94)90022-1 |
0.433 |
|
| 1994 |
Elliott K, Minami N, Kolesnikov YA, Pasternak GW, Inturrisi CE. The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids Pain. 56: 69-75. PMID 7512709 DOI: 10.1016/0304-3959(94)90151-1 |
0.445 |
|
| 1994 |
Kest B, Jenab S, Inturrisi CE. [d-Ala2]Deltorphin II induced tolerance does not alter delta opioid receptor (DOR) mRNA levels in mouse CNS Regulatory Peptides. 54: 147-148. DOI: 10.1016/0167-0115(94)90433-2 |
0.407 |
|
| 1994 |
Jenab S, Inturrisi C. Upregulation of delta opioid receptor gene expression in NG108-15 cells by naloxone and ethanol Regulatory Peptides. 54: 135-136. DOI: 10.1016/0167-0115(94)90427-8 |
0.36 |
|
| 1994 |
Inturrisi CE. NMDA receptors, nitric oxide and opioid tolerance Regulatory Peptides. 54: 129-130. DOI: 10.1016/0167-0115(94)90423-5 |
0.392 |
|
| 1994 |
Cheng P, Svingos A, Clarke C, Inturrisi C, Jenab S, Pickel V. Presynaptic location of δ-opioid receptor immunoreactivity in dorsal horn of the rat spinal cord Regulatory Peptides. 54: 57-58. DOI: 10.1016/0167-0115(94)90387-5 |
0.408 |
|
| 1994 |
Brodsky M, Elliott K, Hynansky A, Inturrisi CE. Strain differences in the analgesic potency of morphine and in mu opioid receptor mRNA levels in adult male mice Regulatory Peptides. 54: 33-34. DOI: 10.1016/0167-0115(94)90375-1 |
0.411 |
|
| 1993 |
Cornish JW, Henson D, Levine S, Volpicelli J, Inturrisi CE, Yoburn BC, O'Brien CP. Naltrexone Maintenance: Effect on Morphine Sensitivity in Normal Volunteers. The American Journal On Addictions. 2: 34-38. PMID 30245561 DOI: 10.3109/10550499309115940 |
0.395 |
|
| 1993 |
Wahlestedt C, Golanov E, Yamamoto S, Yee F, Ericson H, Yoo H, Inturrisi CE, Reis DJ. Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions. Nature. 363: 260-3. PMID 8487863 DOI: 10.1038/363260A0 |
0.333 |
|
| 1993 |
Tiseo PJ, Inturrisi CE. Attenuation and reversal of morphine tolerance by the competitive N- methyl-D-aspartate receptor antagonist, LY274614 Journal of Pharmacology and Experimental Therapeutics. 264: 1090-1096. PMID 8450453 |
0.354 |
|
| 1993 |
Zhu Ys, Inturrisi CE. Metrazole induction of c-fos and proenkephalin gene expression in the rat adrenal and hippocampus: pharmacological characterization Molecular Brain Research. 20: 118-124. PMID 8255173 DOI: 10.1016/0169-328X(93)90116-7 |
0.323 |
|
| 1993 |
Franklin SO, Elliott K, Zhu YS, Wahlestedt C, Inturrisi CE. Quantitation of NMDA receptor (NMDAR1) mRNA levels in the adult and developing rat CNS. Brain Research. Molecular Brain Research. 19: 93-100. PMID 7689684 DOI: 10.1016/0169-328X(93)90153-G |
0.331 |
|
| 1992 |
Culpepper‐Morgan JA, Inturrisi CE, Portenoy RK, Foley K, Houde RW, Marsh F, Kreek MJ. Treatment of opioid‐induced constipation with oral naloxone: A pilot study Clinical Pharmacology &Amp; Therapeutics. 52: 90-95. PMID 1623695 DOI: 10.1038/Clpt.1992.106 |
0.393 |
|
| 1992 |
Portenoy RK, Thaler HT, Inturrisi CE, Friedlander-Klar H, Foley KM. The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function Clinical Pharmacology and Therapeutics. 51: 422-431. PMID 1563212 DOI: 10.1038/Clpt.1992.42 |
0.418 |
|
| 1992 |
Candido J, Lutfy K, Billings B, Sierra V, Duttaroy A, Inturrisi CE, Yoburn BC. Effect of adrenal and sex hormones on opioid analgesia and opioid receptor regulation Pharmacology, Biochemistry and Behavior. 42: 685-692. PMID 1325057 DOI: 10.1016/0091-3057(92)90015-8 |
0.388 |
|
| 1991 |
Hagen NA, Foley KM, Cerbone DJ, Portenoy RK, Inturrisi CE. Chronic nausea and morphine-6-glucuronide Journal of Pain and Symptom Management. 6: 125-128. PMID 2016556 DOI: 10.1016/0885-3924(91)90961-3 |
0.388 |
|
| 1991 |
Portenoy RK, Khan E, Layman M, Lapin J, Malkin MG, Foley KM, Thaler HT, Cerbone DJ, Inturrisi CE. Chronic morphine therapy for cancer pain: Plasma and cerebrospinal fluid morphine and morphine–6–glucuronide concentrations Neurology. 41: 1457-1461. PMID 1891098 DOI: 10.1212/Wnl.41.9.1457 |
0.34 |
|
| 1991 |
Portenoy RK, Foley KM, Stulman J, Khan E, Adelhardt J, Layman M, Cerbone DF, Inturrisi CE. Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failure Pain. 47: 13-19. PMID 1771088 DOI: 10.1097/00132586-199206000-00045 |
0.343 |
|
| 1991 |
Inturrisi CE, Cerbone DJ, Chen D, Yoburn BC, Pasternak GW, Portenoy RK, Foley KM. Species Dependent Accumulation of Morphine-6-Glucuronide (M-6-G) After Morphine (MOR) Administration The Clinical Journal of Pain. 7: 42. DOI: 10.1097/00002508-199103000-00012 |
0.345 |
|
| 1990 |
Inturrisi CE, Portenoy RK, Max MB, Colburn WA, Foley KM. Pharmacokinetic-pharmacodynamic relationships of methadone infusions in patients with cancer pain. Clinical Pharmacology and Therapeutics. 47: 565-77. PMID 2188771 DOI: 10.1038/Clpt.1990.77 |
0.373 |
|
| 1990 |
Eisenach JC, Dobson CE, Inturrisi CE, Hood DD, Agner PB. Effect of pregnancy and pain on cerebrospinal fluid immunoreactive enkephalins and norepinephrine in healthy humans Pain. 43: 149-154. PMID 2087327 DOI: 10.1016/0304-3959(90)91067-S |
0.416 |
|
| 1990 |
Portenoy RK, Foley KM, Inturrisi CE. The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions Pain. 43: 273-286. PMID 1705692 DOI: 10.1016/0304-3959(90)90025-9 |
0.435 |
|
| 1989 |
Paul D, Standifer KM, Inturrisi CE, Pasternak GW. Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite. The Journal of Pharmacology and Experimental Therapeutics. 251: 477-83. PMID 2810109 |
0.315 |
|
| 1989 |
Inturrisi CE. Management of cancer pain. Pharmacology and principles of management Cancer. 63: 2308-2320. PMID 2566371 DOI: 10.1002/1097-0142(19890601)63:11<2308::Aid-Cncr2820631141>3.0.Co;2-D |
0.334 |
|
| 1989 |
Yoburn BC, Kreuscher SP, Inturrisi CE, Sierra V. Opioid receptor upregulation and supersensitivity in mice: Effect of morphine sensitivity Pharmacology, Biochemistry and Behavior. 32: 727-731. PMID 2544906 DOI: 10.1016/0091-3057(89)90025-7 |
0.394 |
|
| 1988 |
Yoburn BC, Inturrisi CE. Modification of the response to opioid and monopioid drugs by chronic opioid antagonist treatment Life Sciences. 42: 1689-1696. PMID 3362035 DOI: 10.1016/0024-3205(88)90034-3 |
0.405 |
|
| 1988 |
Bryant HU, Yoburn BC, Inturrisi CE, Bernton EW, Holaday JW. Morphine-induced immunomodulation is not related to serum morphine concentrations European Journal of Pharmacology. 149: 165-169. PMID 3260867 DOI: 10.1016/0014-2999(88)90057-X |
0.412 |
|
| 1988 |
Yoburn BC, Luke MC, Pasternak GW, Inturrisi CE. Upregulation of opioid receptor subtypes correlates with potency changes of morphine and dadle Life Sciences. 43: 1319-1324. PMID 2845219 DOI: 10.1016/0024-3205(88)90587-5 |
0.402 |
|
| 1988 |
Weinberg DS, Inturrisi CE, Reidenberg B, Moulin DE, Tip TJ, Wallenstein S, Houde RW, Foley KM. Sublingual absorption of selected opioid analgesics Clinical Pharmacology and Therapeutics. 44: 335-342. PMID 2458208 DOI: 10.1038/Clpt.1988.159 |
0.373 |
|
| 1987 |
Inturrisi CE, Colburn WA, Kaiko RF, Houde RW, Foley KM. Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain Clinical Pharmacology and Therapeutics. 41: 392-401. PMID 3829576 DOI: 10.1038/Clpt.1987.47 |
0.357 |
|
| 1987 |
Groeger JS, Inturrisi CE. High-dose naloxone: Pharmacokinetics in patients in septic shock Critical Care Medicine. 15: 751-756. PMID 3608532 DOI: 10.1097/00003246-198708000-00008 |
0.324 |
|
| 1987 |
Foley KM, Inturrisi CE. Analgesic drug therapy in cancer pain: Principles and practice Medical Clinics of North America. 71: 207-232. PMID 2881032 DOI: 10.1016/S0025-7125(16)30866-5 |
0.314 |
|
| 1987 |
Pasternak GW, Bodnar RJ, Clark JA, Inturrisi CE. Morphine-6-glucuronide, a potent mu agonist. Life Sciences. 41: 2845-9. PMID 2826951 DOI: 10.1016/0024-3205(87)90431-0 |
0.398 |
|
| 1987 |
Yoburn BC, Truesdell LS, Kest B, Inturrisi CE, Bodnar RJ. Chronic opioid antagonist treatment facilitates nonopioid, stress-induced analgesia. Pharmacology, Biochemistry, and Behavior. 27: 525-7. PMID 2821554 DOI: 10.1016/0091-3057(87)90359-5 |
0.433 |
|
| 1986 |
Rawal N, Schott U, Dahlstrom B, Inturrisi CE, Tandon B, Sjöstrand U, Wennhager M. Influence of naloxone infusion on analgesia and respiratory depression following epidural morphine Anesthesiology. 64: 194-201. PMID 3946806 DOI: 10.1097/00000542-198602000-00011 |
0.418 |
|
| 1986 |
Payne R, Madsen J, Harvey RC, Inturrisi CE. A chronic sheep preparation for the study of drug pharmacokinetics in spinal and ventricular CSF Journal of Pharmacological Methods. 16: 277-296. PMID 3784573 DOI: 10.1016/0160-5402(86)90032-X |
0.392 |
|
| 1986 |
Moulin DE, Inturrisi CE, Foley KM. Cerebrospinal fluid pharmacokinetics of intrathecal morphine sulfate and D-Ala2-D-Leu5-enkephalin Annals of Neurology. 20: 218-222. PMID 3530119 DOI: 10.1002/Ana.410200207 |
0.392 |
|
| 1986 |
Yoburn BC, Nunes FA, Adler B, Pasternak GW, Inturrisi CE. Pharmacodynamic supersensitivity and opioid receptor upregulation in the mouse Journal of Pharmacology and Experimental Therapeutics. 239: 132-135. PMID 3020228 |
0.306 |
|
| 1985 |
Yoburn BC, Cohen A, Umans JG, Ling GSF, Inturrisi CE. The graded and quantal nature of opioid analgesia in the rat tailflick assay Brain Research. 331: 327-336. PMID 3986573 DOI: 10.1016/0006-8993(85)91558-6 |
0.397 |
|
| 1985 |
Moulin DE, Max MB, Kaiko RF, Inturrisi CE, Maggard J, Yaksh TL, Foley KM. The analgesic efficacy of intrathecal D-Ala2-D-Leu5-enkephalin in cancer patients with chronic pain. Pain. 23: 213-21. PMID 3906516 DOI: 10.1016/0304-3959(85)90099-5 |
0.347 |
|
| 1985 |
Payne R, Inturrisi CE. CSF distribution of morphine, methadone and sucrose after intrathecal injection. Life Sciences. 37: 1137-1144. PMID 3839885 DOI: 10.1016/0024-3205(85)90357-1 |
0.403 |
|
| 1985 |
Yoburn BC, Goodman RR, Cohen AH, Pasternak GW, Inturrisi CE. Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatment. Life Sciences. 36: 2325-32. PMID 2989632 DOI: 10.1016/0024-3205(85)90322-4 |
0.388 |
|
| 1985 |
Max MB, Inturrisi CE, Kaiko RF, Grabinski PY, Li CH, Foley KM. Epidural and intrathecal opiates: cerebrospinal fluid and plasma profiles in patients with chronic cancer pain. Clinical Pharmacology and Therapeutics. 38: 631-41. PMID 2415286 DOI: 10.1038/Clpt.1985.237 |
0.424 |
|
| 1985 |
Inturrisi C, Foley K, Max M, Chen J, Schultz M, Houde R. Disposition and Effects of Heroin in Pain Patients The Clinical Journal of Pain. 1: 111-116. DOI: 10.1097/00002508-198501020-00010 |
0.342 |
|
| 1984 |
Yoburn BC, Morales R, Kelly DD, Inturrisi CE. Constraints on the tailflick assay: Morphine analgesia and tolerance are dependent upon locus of tail stimulation Life Sciences. 34: 1755-1762. PMID 6727545 DOI: 10.1016/0024-3205(84)90575-7 |
0.381 |
|
| 1984 |
Inturrisi CE, Max MB, Foley KM, Schultz M, Shin SU, Houde RW. The pharmacokinetics of heroin in patients with chronic pain. The New England Journal of Medicine. 310: 1213-7. PMID 6709027 DOI: 10.1097/00132586-198412000-00005 |
0.437 |
|
| 1984 |
Ling GSF, Tappe NS, Inturrisi CE. Methadone induced physical dependence in the rat Life Sciences. 34: 683-690. PMID 6538254 DOI: 10.1016/0024-3205(84)90233-9 |
0.382 |
|
| 1984 |
Inturrisi CE. Role of opioid analgesics American Journal of Medicine. 77: 27-37. PMID 6486129 DOI: 10.1016/S0002-9343(84)80100-X |
0.358 |
|
| 1983 |
Inturrisi CE, Schultz M, Shin S, Umans JG, Angel L, Simon EJ. Evidence from opiate binding studies that heroin acts through its metabolites Life Sciences. 33: 773-776. PMID 6319928 DOI: 10.1016/0024-3205(83)90616-1 |
0.31 |
|
| 1983 |
Kaiko RF, Foley KM, Grabinski PY, Heidrich G, Rogers AG, Inturrisi CE, Reidenberg MM. Central nervous system excitatory effects of meperidine in cancer patients Annals of Neurology. 13: 180-185. PMID 6187275 DOI: 10.1002/Ana.410130213 |
0.338 |
|
| 1983 |
Perry S, Inturrisi CE. Clinical Research: Analgesia and Morphine Disposition in Burn Patients Journal of Burn Care & Rehabilitation. 4: 276-279. DOI: 10.1097/00004630-198307000-00007 |
0.382 |
|
| 1982 |
Umans JG, Inturrisi CE. Heroin: Analgesia, toxicity and disposition in the mouse European Journal of Pharmacology. 85: 317-323. PMID 7151874 DOI: 10.1016/0014-2999(82)90218-7 |
0.327 |
|
| 1981 |
Max M, Inturrisi CE, Grabinski P. Epidural opiates: Plasma and cerebrospinal fluid (CSF) pharmacokinetics of morphine, methadone and beta-endorphin Pain. 10. DOI: 10.1016/0304-3959(81)90353-5 |
0.323 |
|
| 1980 |
Inturrisi CE, Umans JG, Wolff D, Stern AS, Lewis RV, Stein S, Udenfriend S. Analgesic activity of the naturally occurring heptapeptide [Met]enkephalin-Arg6-Phe7. Proceedings of the National Academy of Sciences of the United States of America. 77: 5512-4. PMID 6933569 DOI: 10.1073/Pnas.77.9.5512 |
0.406 |
|
| 1979 |
Yaksh TL, Wilson PR, Kaiko RF, Inturrisi CE. Analgesia produced by a spinal action of morphine and effects upon parturition in the rat Anesthesiology. 51: 386-392. PMID 582883 DOI: 10.1097/00132586-198008000-00057 |
0.399 |
|
| 1979 |
Foley KM, Kourides IA, Inturrisi CE, Kaiko RF, Zaroulis CG, Posner JB, Houde RW, Li CH. β-Endorphin: Analgesic and hormonal effects in humans Proceedings of the National Academy of Sciences of the United States of America. 76: 5377-5381. PMID 291954 DOI: 10.1073/Pnas.76.10.5377 |
0.329 |
|
| 1976 |
Chattergie N, Umans JG, Inturrisi CE. Reduction of 6-ketones of the morphine series with formamidinesulfinic acid. Stereoselectivity opposite to that of hydride reductions Journal of Organic Chemistry. 41: 3624-3625. PMID 978305 DOI: 10.1002/Chin.197707342 |
0.317 |
|
| 1975 |
Fujimoto JM, Roerig S, Wang RIH, Chatterjie N, Inturrisi CE. Narcotic antagonist activity of several metabolites of naloxone and naltrexone tested in morphine dependent mice (38558). Experimental Biology and Medicine. 148: 443-448. PMID 1168347 DOI: 10.3181/00379727-148-38558 |
0.313 |
|
| 1968 |
Inturrisi CE, Fujimoto JM. The development of tolerance to the antidiuretic effect of morphine in the mouse Toxicology and Applied Pharmacology. 13: 258-270. PMID 5726417 DOI: 10.1016/0041-008X(68)90100-2 |
0.372 |
|
| 1968 |
Inturrisi CE, Fujimoto JM. The antidiuretic effect of narcotic analgesics in the mouse. Toxicology and Applied Pharmacology. 13: 251-257. PMID 5726416 DOI: 10.1016/0041-008X(68)90099-9 |
0.374 |
|
| 1968 |
Inturrisi CE, May DG, Fujimoto JM. The diuretic effect of morphine in the chicken European Journal of Pharmacology. 5: 79-84. PMID 5718521 DOI: 10.1016/0014-2999(68)90159-3 |
0.384 |
|
| 1968 |
Inturrisi CE, Fujimoto JM. Studies on the antidiuretic action of mophine in the rat European Journal of Pharmacology. 2: 301-307. PMID 5642033 DOI: 10.1016/0014-2999(68)90081-2 |
0.302 |
|
| Show low-probability matches. |